FDA warns on abortion pill infection risk

Share this article:
The FDA warned doctors yesterday to be on the lookout for rare but deadly bacterial infections in women using Danco Laboratories' abortion pill RU-486.
The warning stated that four women have died from sepsis, an infection of the bloodstream, following use of the drug, also known as Mifeprex.
Although all of the cases were reported in California and involve the off-label use of the drug, the FDA is asking all doctors to look for the symptoms of the infection while the agency reviews the cases.
 
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters